CEPTON MEDICATED SKIN WASH

Main information

  • Trade name:
  • CEPTON MEDICATED SKIN WASH
  • Dosage:
  • 1 %w/ v
  • Pharmaceutical form:
  • Cutaneous Solution
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • CEPTON MEDICATED SKIN WASH
    Ireland
  • Language:
  • English

Status

  • Source:
  • HPRA - Health Products Regulatory Authority - Ireland
  • Authorization number:
  • PA0739/003/003
  • Authorization date:
  • 26-06-1996
  • Last update:
  • 14-10-2016

Summary of Product characteristics: dosage, interactions, side effects

PartII

SummaryofProductCharacteristics

1NAMEOFTHEMEDICINALPRODUCT

CeptonMedicatedSkinWash

2QUALITATIVEANDQUANTITATIVECOMPOSITION

Activeingredient:ChlorhexidineGluconate1.0%w/v

3PHARMACEUTICALFORM

Cutaneoussolution.

4CLINICALPARTICULARS

4.1TherapeuticIndications

Fordailyuseinthetreatmentandpreventionofspotsandacne.

4.2Posologyandmethodofadministration

Fortopicaluseonly

Applymorningandnightasfollows:

Washhandsandface

Washwithundilutedmedicatedskinwash,thenrinse.Repeat.

Formaximumeffect,leavesecondwashonskinforoneminutebeforerinsing.

4.3Contraindications

Noneknown.

4.4Specialwarningsandprecautionsforuse

Forexternaluseonly

Keepallmedicinesawayfromchildren

Ifskinirritationoccursstopusingandtalktoyourdoctor

Keepoutoftheeyesandears

Treataccidentalsplashesintotheeyesbywashingoutimmediatelywithwaterandseekmedicaladvice

4.5Interactionwithothermedicinalproductsandotherformsofinteraction

Noneknown.

4.6Pregnancyandlactation

Irish Medicines Board

______________________________________________________________________________________________________________________

Date Printed 28/05/2010 CRN 2083457 page number: 1

4.7Effectsonabilitytodriveandusemachines

Theabilitytodriveorusemachinesisnotaffected.

4.8Undesirableeffects

Noneknown.

4.9Overdose

Ifswallowed,washoutthemouthanddrinkplentyofmilkorwater;seekmedicaladvice.

5PHARMACOLOGICALPROPERTIES

5.1Pharmacodynamicproperties

Chlorhexidineisaneffectiveantisepticwithawiderangeofactivityagainstmicro-organisms,includinggrampositive

andgramnegativebacteria,fungiandviruses.

5.2Pharmacokineticproperties

Notapplicable.

5.3Preclinicalsafetydata

Notapplicable.

6PHARMACEUTICALPARTICULARS

6.1Listofexcipients

Polyoxyethylenepolyoxypropyleneblockco-polymer

Lauryldimethylamineoxide

Ponceau4R(E124)

Isopropylalcohol

Perfume

D-gluconolactone

Sodiumhydroxide

Purifiedwater

6.2Incompatibilities

Noneknown.

6.3ShelfLife

3years.

6.4Specialprecautionsforstorage

Donotstoreabove25 °

Irish Medicines Board

______________________________________________________________________________________________________________________

Date Printed 28/05/2010 CRN 2083457 page number: 2

6.5Natureandcontentsofcontainer

Highdensitypolyethylenebottlewithscrewcapclosure.

Packsizes:50,100,150and250ml.

6.6Specialprecautionsfordisposalofausedmedicinalproductorwastematerialsderivedfrom

suchmedicinalproductandotherhandlingoftheproduct

Nospecialrequirements.

7MARKETINGAUTHORISATIONHOLDER

EasternPharmaceuticalsLimited,

CoombHouse,7St.John’sRoad,

Isleworth,

MiddlesexTW76NA,

UnitedKingdom.

8MARKETINGAUTHORISATIONNUMBER

PA0739/003/003

9DATEOFFIRSTAUTHORISATION/RENEWALOFTHEAUTHORISATION

Dateoffirstauthorisation:26June1991

Irish Medicines Board

______________________________________________________________________________________________________________________

Date Printed 28/05/2010 CRN 2083457 page number: 3